Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Axsome Therapeutics (AXSM) PT Lowered to $130 at RBC Capital

August 6, 2024 6:42 AM EDT

RBC Capital analyst Leonid Timashev lowered the price target on Axsome Therapeutics (NASDAQ: AXSM) to $130.00 (from $131.00) while maintaining a Outperform rating.

The analyst comments "This morning AXSM reported 2Q24 earnings where we saw continued growth for Auvelity and major... More